- Home
- NOTV vs AIFE Comparison
NOTV vs AIFE Comparison
Compare NOTV & AIFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOTV
- AIFE
- Stock Information
- Founded
- NOTV 1974
- AIFE 2024
- Country
- NOTV United States
- AIFE United States
- Employees
- NOTV N/A
- AIFE N/A
- Industry
- NOTV Biotechnology: Pharmaceutical Preparations
- AIFE
- Sector
- NOTV Health Care
- AIFE
- Exchange
- NOTV Nasdaq
- AIFE NYSE
- Market Cap
- NOTV 137.5M
- AIFE 111.4M
- IPO Year
- NOTV 1997
- AIFE N/A
- Fundamental
- Price
- NOTV $1.96
- AIFE $10.10
- Analyst Decision
- NOTV Strong Buy
- AIFE
- Analyst Count
- NOTV 3
- AIFE 0
- Target Price
- NOTV $6.25
- AIFE N/A
- AVG Volume (30 Days)
- NOTV 840.6K
- AIFE 14.5K
- Earning Date
- NOTV 05-07-2025
- AIFE 01-01-0001
- Dividend Yield
- NOTV N/A
- AIFE N/A
- EPS Growth
- NOTV N/A
- AIFE N/A
- EPS
- NOTV N/A
- AIFE N/A
- Revenue
- NOTV $480,402,000.00
- AIFE N/A
- Revenue This Year
- NOTV $5.84
- AIFE N/A
- Revenue Next Year
- NOTV $5.74
- AIFE N/A
- P/E Ratio
- NOTV N/A
- AIFE N/A
- Revenue Growth
- NOTV N/A
- AIFE N/A
- 52 Week Low
- NOTV $1.15
- AIFE $9.89
- 52 Week High
- NOTV $6.48
- AIFE $10.13
- Technical
- Relative Strength Index (RSI)
- NOTV 47.15
- AIFE N/A
- Support Level
- NOTV $1.75
- AIFE N/A
- Resistance Level
- NOTV $2.36
- AIFE N/A
- Average True Range (ATR)
- NOTV 0.18
- AIFE 0.00
- MACD
- NOTV 0.07
- AIFE 0.00
- Stochastic Oscillator
- NOTV 45.95
- AIFE 0.00
About NOTV Inotiv Inc.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
About AIFE AIFEEX NEXUS ACQUISITION CORPO
Aifeex Nexus Acquisition Corp is a blank check company.